Basic Information
RNALocate ID: | RLID:11001718 |
RNA Symbol: | hsa-miR-125b-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-125b-5p |
RNA ID: | miRBase:MIMAT0000423 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001753 | Cytoplasm | Neural progenitor cells | 21363885 |
RLID:01001754 | Cytoplasm | Cell line (HeLa) | 21695135 |
RLID:01001755 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001756 | Mitochondrion | Myotube | 27396686 |
RLID:01001757 | Mitochondrion | Skeletal muscle cells | 27563705 |
RLID:01001758 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001759 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001760 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001761 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001762 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:11001715 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
RLID:11001716 | Exosome | Primary dendritic cells | 21505438 |
RLID:11001717 | Exosome | Brain tissue | 23382797 |
RLID:11001719 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11001720 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001721 | Microvesicle | Follicular fluid | 23666971 |
RLID:11001722 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000076 | Exosome | Blood|Breast milk|Endothelial cells|Epithelial cells|Seminal fluid | |
RLID-D:11000351 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-125b-5p | Diffuse large b cell lymphoma | MNDR-E-MI-07449 |
MNDR | hsa-miR-125b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-07450 |
MNDR | hsa-miR-125b-5p | Colorectal adenoma | MNDR-E-MI-07451 |
MNDR | hsa-miR-125b-5p | Oral squamous cell carcinoma | MNDR-E-MI-07452 |
MNDR | hsa-miR-125b-5p | Medulloblastoma | MNDR-E-MI-07453 |
MNDR | hsa-miR-125b-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-07454 |
MNDR | hsa-miR-125b-5p | Ovarian clear cell carcinoma | MNDR-E-MI-07455 |
MNDR | hsa-miR-125b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-07456 |
MNDR | hsa-miR-125b-5p | Lymphoma | MNDR-E-MI-07457 |
MNDR | hsa-miR-125b-5p | Lymphoma non-hodgkin | MNDR-E-MI-07458 |
MNDR | hsa-miR-125b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-07459 |
MNDR | hsa-miR-125b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-07460 |
MNDR | hsa-miR-125b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-07461 |
MNDR | hsa-miR-125b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-07462 |
MNDR | hsa-miR-125b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-07463 |
MNDR | hsa-miR-125b-5p | Acute promyelocytic leukemia | MNDR-E-MI-07464 |
MNDR | hsa-miR-125b-5p | Breast cancer luminal | MNDR-E-MI-07465 |
MNDR | hsa-miR-125b-5p | Anaplastic thyroid cancer | MNDR-E-MI-07466 |
MNDR | hsa-miR-125b-5p | B-cell acute lymphoblastic leukemia | MNDR-E-MI-07467 |
MNDR | hsa-miR-125b-5p | Prostate cancer | MNDR-E-MI-07468 |
MNDR | hsa-miR-125b-5p | Chronic lymphocytic leukemia | MNDR-E-MI-07469 |
MNDR | hsa-miR-125b-5p | Gastric cancer | MNDR-E-MI-07470 |
MNDR | hsa-miR-125b-5p | Gastric lymphoma | MNDR-E-MI-07471 |
MNDR | hsa-miR-125b-5p | Alzheimer disease | MNDR-E-MI-07472 |
MNDR | hsa-miR-125b-5p | Intracranial aneurysm | MNDR-E-MI-07473 |
MNDR | hsa-miR-125b-5p | Bladder cancer | MNDR-E-MI-07474 |
MNDR | hsa-miR-125b-5p | Respiratory distress syndrome adult | MNDR-E-MI-07475 |
MNDR | hsa-miR-125b-5p | Dysautonomia familial | MNDR-E-MI-07476 |
MNDR | hsa-miR-125b-5p | Myotonic dystrophy | MNDR-E-MI-07477 |
MNDR | hsa-miR-125b-5p | Head and neck cancer | MNDR-E-MI-07478 |
MNDR | hsa-miR-125b-5p | Leukemia | MNDR-E-MI-07479 |
MNDR | hsa-miR-125b-5p | Ataxia telangiectasia | MNDR-E-MI-07480 |
MNDR | hsa-miR-125b-5p | Friedreich ataxia | MNDR-E-MI-07481 |
MNDR | hsa-miR-125b-5p | Huntington disease | MNDR-E-MI-07482 |
MNDR | hsa-miR-125b-5p | Cardiovascular disease | MNDR-E-MI-07483 |
MNDR | hsa-miR-125b-5p | Carotid stenosis | MNDR-E-MI-07484 |
MNDR | hsa-miR-125b-5p | Uterine fibroid | MNDR-E-MI-07485 |
MNDR | hsa-miR-125b-5p | Lung cancer | MNDR-E-MI-07486 |
MNDR | hsa-miR-125b-5p | Down syndrome | MNDR-E-MI-07487 |
MNDR | hsa-miR-125b-5p | Fragile x syndrome | MNDR-E-MI-07488 |
MNDR | hsa-miR-125b-5p | Parkinson disease | MNDR-E-MI-07489 |
MNDR | hsa-miR-125b-5p | Machado-joseph disease | MNDR-E-MI-07490 |
MNDR | hsa-miR-125b-5p | Colonic adenomas | MNDR-E-MI-07491 |
MNDR | hsa-miR-125b-5p | Breast cancer | MNDR-E-MI-07492 |
MNDR | hsa-miR-125b-5p | Vascular diseases | MNDR-E-MI-07493 |
MNDR | hsa-miR-125b-5p | Pituitary neoplasms | MNDR-E-MI-07494 |
MNDR | hsa-miR-125b-5p | Pancreatic cancer | MNDR-E-MI-07495 |
MNDR | hsa-miR-125b-5p | Melanoma | MNDR-E-MI-07496 |
MNDR | hsa-miR-125b-5p | Williams syndrome | MNDR-E-MI-07497 |
MNDR | hsa-miR-125b-5p | Rectum adenocarcinoma | MNDR-E-MI-07498 |
MNDR | hsa-miR-125b-5p | Hepatitis B | MNDR-E-MI-07499 |
MNDR | hsa-miR-125b-5p | Colon cancer | MNDR-E-MI-07500 |
MNDR | hsa-miR-125b-5p | Colon adenocarcinoma | MNDR-E-MI-07501 |
MNDR | hsa-miR-125b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-07502 |
MNDR | hsa-miR-125b-5p | Ovarian cancer | MNDR-E-MI-07503 |
MNDR | hsa-miR-125b-5p | Acromegaly | MNDR-E-MI-07504 |
MNDR | hsa-miR-125b-5p | Cerebellar disease | MNDR-E-MI-07505 |
MNDR | hsa-miR-125b-5p | Endometrial carcinoma | MNDR-E-MI-07506 |
MNDR | hsa-miR-125b-5p | Laryngeal squamous cell carcinoma | MNDR-E-MI-07507 |
MNDR | hsa-miR-125b-5p | Endometriosis | MNDR-E-MI-07508 |
MNDR | hsa-miR-125b-5p | Thyroid adenomas | MNDR-E-MI-07509 |
MNDR | hsa-miR-125b-5p | Carcinoma ductal breast | MNDR-E-MI-07510 |
MNDR | hsa-miR-125b-5p | Glioblastoma | MNDR-E-MI-07511 |
MNDR | hsa-miR-125b-5p | Astrocytoma | MNDR-E-MI-07512 |
MNDR | hsa-miR-125b-5p | Glioma | MNDR-E-MI-07513 |
MNDR | hsa-miR-125b-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-07514 |
MNDR | hsa-miR-125b-5p | Oligodendroglioma | MNDR-E-MI-07515 |
MNDR | hsa-miR-125b-5p | Paraparesis tropical spastic | MNDR-E-MI-07516 |
MNDR | hsa-miR-125b-5p | Chordoma | MNDR-E-MI-07517 |
MNDR | hsa-miR-125b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-07518 |
MNDR | hsa-miR-125b-5p | Epilepsy temporal lobe | MNDR-E-MI-07519 |
MNDR | hsa-miR-125b-5p | Osteosarcoma | MNDR-E-MI-07520 |
MNDR | hsa-miR-125b-5p | Liposarcoma | MNDR-E-MI-07521 |
MNDR | hsa-miR-125b-5p | Breast carcinoma | MNDR-E-MI-07522 |
MNDR | hsa-miR-125b-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-07523 |
MNDR | hsa-miR-125b-5p | Meningioma | MNDR-E-MI-07524 |
MNDR | hsa-miR-125b-5p | Cervical adenocarcinoma | MNDR-E-MI-07525 |
MNDR | hsa-miR-125b-5p | Gastric adenocarcinoma | MNDR-E-MI-07526 |
MNDR | hsa-miR-125b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-07527 |
MNDR | hsa-miR-125b-5p | Pituitary adenoma | MNDR-E-MI-07528 |
MNDR | hsa-miR-125b-5p | Lung squamous cell carcinoma | MNDR-E-MI-07529 |
MNDR | hsa-miR-125b-5p | Carcinoma lung non-small-cell | MNDR-E-MI-07530 |
MNDR | hsa-miR-125b-5p | Lung adenocarcinoma | MNDR-E-MI-07531 |
MNDR | hsa-miR-125b-5p | Adrenocortical carcinoma | MNDR-E-MI-07532 |
MNDR | hsa-miR-125b-5p | Thyroid carcinoma | MNDR-E-MI-07533 |
MNDR | hsa-miR-125b-5p | Ovarian carcinoma | MNDR-E-MI-07534 |
MNDR | hsa-miR-125b-5p | Bladder urothelial carcinoma | MNDR-E-MI-07535 |
MNDR | hsa-miR-125b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-07536 |
MNDR | hsa-miR-125b-5p | Skin cancer | MNDR-E-MI-07537 |
MNDR | hsa-miR-125b-5p | Cervical cancer | MNDR-E-MI-07538 |
MNDR | hsa-miR-125b-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-07539 |
MNDR | hsa-miR-125b-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-07540 |
MNDR | hsa-miR-125b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-07541 |
MNDR | hsa-miR-125b-5p | Renal clear cell carcinoma | MNDR-E-MI-07542 |
MNDR | hsa-miR-125b-5p | Biliary tract cancer | MNDR-E-MI-07543 |
MNDR | hsa-miR-125b-5p | Cholangiocarcinoma | MNDR-E-MI-07544 |
MNDR | hsa-miR-125b-5p | Esophageal cancer | MNDR-E-MI-07545 |
MNDR | hsa-miR-125b-5p | Liver cirrhosis | MNDR-E-MI-07546 |
MNDR | hsa-miR-125b-5p | Arteriosclerosis obliterans | MNDR-E-MI-07547 |
MNDR | hsa-miR-125b-5p | Lung small cell carcinoma | MNDR-E-MI-07548 |
MNDR | hsa-miR-125b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-07549 |
MNDR | hsa-miR-125b-5p | Heart failure | MNDR-E-MI-07550 |
MNDR | hsa-miR-125b-5p | Aortic valve disease | MNDR-E-MI-07551 |
MNDR | hsa-miR-125b-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-07552 |
MNDR | hsa-miR-125b-5p | Fibromyalgia | MNDR-E-MI-07553 |
MNDR | hsa-miR-125b-5p | Breast invasive carcinoma | MNDR-E-MI-07554 |
MNDR | hsa-miR-125b-5p | Cerebrovascular disease | MNDR-E-MI-07555 |
MNDR | hsa-miR-125b-5p | Endometrioid endometrial cancer | MNDR-E-MI-07556 |
MNDR | hsa-miR-125b-5p | Early hepatocellular carcinoma | MNDR-E-MI-07557 |
MNDR | hsa-miR-125b-5p | B-cell lymphoma | MNDR-E-MI-07558 |
MNDR | hsa-miR-125b-5p | Rheumatoid arthritis | MNDR-E-MI-07559 |
MNDR | hsa-miR-125b-5p | T-cell leukemia | MNDR-E-MI-07560 |
MNDR | hsa-miR-125b-5p | Retinoblastoma | MNDR-E-MI-07561 |
MNDR | hsa-miR-125b-5p | Neuroblastoma | MNDR-E-MI-07562 |
MNDR | hsa-miR-125b-5p | Barrett's adenocarcinoma | MNDR-E-MI-07563 |
MNDR | hsa-miR-125b-5p | Hodgkin lymphoma | MNDR-E-MI-07564 |
MNDR | hsa-miR-125b-5p | Burkitt lymphoma | MNDR-E-MI-07565 |
MNDR | hsa-miR-125b-5p | Tonsil cancer | MNDR-E-MI-07566 |
MNDR | hsa-miR-125b-5p | Psoriasis | MNDR-E-MI-07567 |
MNDR | hsa-miR-125b-5p | Skin cutaneous melanoma | MNDR-E-MI-07568 |
MNDR | hsa-miR-125b-5p | Skin melanoma | MNDR-E-MI-07569 |
MNDR | hsa-miR-125b-5p | Acute myeloid leukemia | MNDR-E-MI-07570 |
MNDR | hsa-miR-125b-5p | Gastrointestinal stromal tumor | MNDR-E-MI-07571 |
MNDR | hsa-miR-125b-5p | Colorectal cancer | MNDR-E-MI-07572 |
MNDR | hsa-miR-125b-5p | Nasopharynx carcinoma | MNDR-E-MI-07573 |
MNDR | hsa-miR-125b-5p | Multiple myeloma | MNDR-E-MI-07574 |
MNDR | hsa-miR-125b-5p | Ovarian epithelial cancer | MNDR-E-MI-07575 |
MNDR | hsa-miR-125b-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-07576 |
MNDR | hsa-miR-125b-5p | Uterine cervical neoplasms | MNDR-E-MI-07577 |
MNDR | hsa-miR-125b-5p | Ependymoma | MNDR-E-MI-07578 |
MNDR | hsa-miR-125b-5p | Cardiac hypertrophy | MNDR-E-MI-07579 |
MNDR | hsa-miR-125b-5p | Nasopharyngeal cancer | MNDR-E-MI-07580 |
MNDR | hsa-miR-125b-5p | Prostatic neoplasms | MNDR-E-MI-07581 |
MNDR | hsa-miR-125b-5p | Sleep deprivation | MNDR-E-MI-07582 |
MNDR | hsa-miR-125b-5p | Sepsis | MNDR-E-MI-07583 |
MNDR | hsa-miR-125b-5p | Epstein-barr virus infections | MNDR-E-MI-07584 |
MNDR | hsa-miR-125b-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-07585 |
MNDR | hsa-miR-125b-5p | Gait ataxia | MNDR-E-MI-07586 |
MNDR | hsa-miR-125b-5p | Paraparesis spastic | MNDR-E-MI-07587 |
MNDR | hsa-miR-125b-5p | Delayed graft function | MNDR-E-MI-07588 |
MNDR | hsa-miR-125b-5p | Stroke lacunar | MNDR-E-MI-07589 |
MNDR | hsa-miR-125b-5p | Barrett's carcinogenesis | MNDR-E-MI-07590 |
MNDR | hsa-miR-125b-5p | Breast cancer her3+ negative | MNDR-E-MI-07591 |
MNDR | hsa-miR-125b-5p | Cerebellar neurodegeneration | MNDR-E-MI-07592 |
MNDR | hsa-miR-125b-5p | Cutaneous squamous cell carcinoma | MNDR-E-MI-07593 |
MNDR | hsa-miR-125b-5p | High grade dysplastic nodule | MNDR-E-MI-07594 |
MNDR | hsa-miR-125b-5p | HPV | MNDR-E-MI-07595 |
MNDR | hsa-miR-125b-5p | Neuroinflammation | MNDR-E-MI-07596 |
MNDR | hsa-miR-125b-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-07597 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABTB1 | Homo sapiens | RR00027990 |
TOP